Serum Albumin
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
AAT) After Portal Vein Injection of Recombinant Adeno-Associated Virus (Raav) Vectors
Gene Therapy (2001) 8, 1299–1306 2001 Nature Publishing Group All rights reserved 0969-7128/01 $15.00 www.nature.com/gt RESEARCH ARTICLE Stable therapeutic serum levels of human alpha-1 antitrypsin (AAT) after portal vein injection of recombinant adeno-associated virus (rAAV) vectors S Song1,4, J Embury2,4, PJ Laipis2,4, KI Berns1,4, JM Crawford2 and TR Flotte1,4 Departments of 1Pediatrics, 2Biochemistry and Molecular Biology, and 3Pathology, and 4Powell Gene Therapy Centre of the University of Florida Genetics Institute, University of Florida, Gainesville, FL, USA Previous work from our group showed that recombinant after portal vein injection of doses of 4 × 109 infectious units adeno-associated virus (rAAV) vectors mediated long-term (IU), a 10-fold lower dose than that required for similar levels secretion of therapeutic serum levels of human alpha-1 anti- of expression via the i.m. route. Serum levels greater than trypsin (hAAT) after a single injection in murine muscle. We 1 mg/ml were achieved at doses of 3 × 1010 IU. Southern hypothesized that hepatocyte transduction could be even blotting of liver DNA revealed the presence of circular episo- more efficient, since these cells represent the natural site of mal vector genomes. Immunostaining showed that trans- AAT production and secretion. To test this hypothesis, rAAV gene expression was scattered throughout the liver paren- vectors containing the hAAT cDNA driven by either the chyma. Similar results were obtained with a rAAV-CB-green human elongation factor 1 alpha promoter, the human cyto- fluorescent protein (GFP) vector. There was no evidence of megalovirus immediate–early promoter (CMV), or the CMV- hepatic toxicity. -
Alpha1-Antitrypsin, a Reliable Endogenous Marker for Intestinal Protein Loss and Its Application in Patients with Crohn's Disease
Gut: first published as 10.1136/gut.24.8.718 on 1 August 1983. Downloaded from Gut, 1983, 24, 718-723 Alpha1-antitrypsin, a reliable endogenous marker for intestinal protein loss and its application in patients with Crohn's disease U KARBACH, K EWE, AND H BODENSTEIN From the I. Medizinische Klinik und Poliklinik, Mainz, FR Germany. SUMMARY Intestinal protein loss is generally determined by radio-labelled macromolecules. Alpha1-antitrypsin has been proposed as an endogenous marker for protein losing enteropathy, but different opinions exist about its reliability. In 25 patients with Crohn's disease faecal protein loss was studied with intestinal alpha1-antitrypsin (x1AT) clearance. Simultaneously, in 10 patients x1AT clearance was compared with faecal 51Cr clearance after intravenous 51Cr-albumin injection. There was a linear relation (p<0O05) between X1AT clearance and 51Cr clearance in these cases. In all patients ox1AT clearance was raised above control values. &1AT clearance, however, did not correlate with the activity index of Crohn's disease.1 This index does not contain direct critieria of intestinal inflammation, does not take into account localisation or extent of inflammation, and includes complications such as extraintestinal manifestations, fistuli, stenoses not necessarily related to actual mucosal involvement. It is concluded that x1AT is a reliable marker for intestinal protein loss and that the intestinal changes of Crohn's disease generally lead to an increased protein exudation into the gut. http://gut.bmj.com/ Gastrointestinal loss of plasma proteins can be clearance with the conventional 5 Cr-albumin detected by a variety of labelled macromolecules: method. According to Keaney and Kelleherl° the 59Fe-labelled dextran and 131I_PVP3 are not split by contradictory results could be caused by a difference digestive enzymes; the radioactive isotopes 51Cr- in methods and by comparison of different albumin,4 67Cu-ceruloplasmins or 95Nb-albumin6 are parameters. -
The Importance of Early Identification of Alpha-1 Antitrypsin Deficiency
Open Access Case Report DOI: 10.7759/cureus.3494 The Importance of Early Identification of Alpha-1 Antitrypsin Deficiency Barjinder S. Buttar 1 , Mark Bernstein 1 1. Internal Medicine, Zucker School of Medicine / Northwell Health Mather Hospital, Port Jefferson, USA Corresponding author: Barjinder S. Buttar, [email protected] Abstract Alpha-1 antitrypsin deficiency (AATD) is a common genetic disorder that is easily managed if diagnosed and treated at an early age. It is often missed, however, especially in patients with long histories of smoking and alcohol use. This is mainly due to a lack of awareness and proper screening of the disorder, especially in the primary care setting. Here, we will focus on a case report of a young male whose diagnosis and treatment of AATD was significantly delayed. His lung and liver complications had initially been attributed to his smoking and drinking history. This delay could have been avoided by increasing awareness of AATD and through the implementation of novel screening tests that can quickly rule out the disorder in patients presenting with lung and liver disease. Categories: Internal Medicine, Preventive Medicine, Rheumatology Keywords: aatd, emphysema, copd, cirrhosis, prolastin, screening, alpha-1 antitrypsin deficiency Introduction Alpha-1 antitrypsin deficiency (AATD) is a common autosomal recessive disorder. Alpha-1 antitrypsin (AAT) is defined as a protease inhibitor which is encoded by the SERPINA1 gene. M refers to the normal allele while Z refers to the mutated allele. The mutated Z allele is carried by approximately 2 - 3% of the Caucasian population in the United States. Homozygosity of the Z allele, PI*ZZ, is the most common mutation that leads to AATD [1]. -
Plasma Protein Binding Structure Activity Relationship Related to the N-Terminus of Daptomycin
Monash Institute of Pharmaceutical P1318 Sciences ECCMID 2017, Plasma protein binding structure activity relationship related to the N-terminus of daptomycin 381 Royal Parade, Parkville, VIC 3052 Melbourne, Australia Vienna 1 2 3 2 4 1 Tel: +61 3 9903 9539 Elena K. Schneider , Johnny X. Huang , Vincenzo Carbone , Matthew A. Cooper , Jian Li *, Tony Velkov * [email protected] 1Drug Development and Innovation, Drug Delivery, Disposition and Dynamics. Monash Institute of Pharmaceutical Sciences, Monash University, Australia. 2Institute for Molecular Bioscience, The University of Queensland St Lucia QLD 4072. 3Animal Nutrition and Health, Ag Research Limited, Grasslands Research Centre, Palmerston North, New Zealand. 4Monash Biomedicine Discovery Institute, Department of Microbiology, Monash University, Australia. Abstract Methods Results Background: Daptomycin is a lipopeptide antibiotic that is highly bound to plasma proteins. To date the plasma components and • Flourometric binding assay: • SPR: structure-activity relationships responsible for the plasma protein binding profile of daptomycin remain uncharacterized. We used the site selective fluorescent probes . Native daptomycin binds in order of decreasing Methods: dansylamide (site 1) and dansylsarcosine affinity to: HSA >> α-1-antitrypsin > low density (site 2) on HSA. As the control we employed lipoprotein (LDL) ≥ haemoglobin > sex hormone • In the present study we have employed surface plasmon resonance (SPR) and fluorescence displacement assay to Nifedipine for site 1 and ibuprofen -
Detailed Structure and Pathophysiological Roles of the Iga-Albumin Complex in Multiple Myeloma
International Journal of Molecular Sciences Article Detailed Structure and Pathophysiological Roles of the IgA-Albumin Complex in Multiple Myeloma Yuki Kawata 1, Hisashi Hirano 1, Ren Takahashi 1, Yukari Miyano 1, Ayuko Kimura 1, Natsumi Sato 1, Yukio Morita 2, Hirokazu Kimura 1,* and Kiyotaka Fujita 1 1 Department of Health Sciences, Gunma Paz University Graduate School of Health Sciences, 1-7-1, Tonyamachi, Takasaki-shi, Gunma 370-0006, Japan; [email protected] (Y.K.); [email protected] (H.H.); [email protected] (R.T.); [email protected] (Y.M.); [email protected] (A.K.); [email protected] (N.S.); [email protected] (K.F.) 2 Laboratory of Public Health II, Azabu University School of Veterinary Medicine, 1-17-71, Fuchinobe, Chuo-ku, Sagamihara, Kanagawa 252-5201, Japan; [email protected] * Correspondence: [email protected]; Tel.: +81-27-365-3366; Fax: +81-27-388-0386 Abstract: Immunoglobulin A (IgA)-albumin complexes may be associated with pathophysiology of multiple myeloma, although the etiology is not clear. Detailed structural analyses of these protein– protein complexes may contribute to our understanding of the pathophysiology of this disease. We analyzed the structure of the IgA-albumin complex using various electrophoresis, mass spectrom- etry, and in silico techniques. The data based on the electrophoresis and mass spectrometry showed that IgA in the sera of patients was dimeric, linked via the J chain. Only dimeric IgA can bind to albumin molecules leading to IgA-albumin complexes, although both monomeric and dimeric forms of IgA were present in the sera. -
Efficacy and Safety of Human Serum Albumin–Cisplatin Complex In
International Journal of Molecular Sciences Article Efficacy and Safety of Human Serum Albumin–Cisplatin Complex in U87MG Xenograft Mouse Models Cho Rong Park 1,2,3, Hyo Young Kim 1,2, Myung Geun Song 1,2,4,*, Yun-Sang Lee 1,5, Hyewon Youn 1,2,6, June-Key Chung 1,2,3,4, Gi Jeong Cheon 1,2,4,5,7 and Keon Wook Kang 1,2,3,4,5,6,8,* 1 Department of Nuclear Medicine, Seoul National University Hospital, 101 Daehak-ro, Jongno-gu, Seoul 03080, Korea; siofl[email protected] (C.R.P.); [email protected] (H.Y.K.); [email protected] (Y.-S.L.); [email protected] (H.Y.); [email protected] (J.-K.C.); [email protected] (G.J.C.) 2 Laboratory of Molecular Imaging and Therapy, Cancer Research Institute, Seoul 03080, Korea 3 Department of Biomedical Sciences, Seoul National University Graduate School, Biomedical Science Building, Seoul 03080, Korea 4 Biomedical Research Institute, Seoul National University Hospital, Seoul 03080, Korea 5 Radiation Research Institute, Seoul National University College of Medicine, Seoul 03080, Korea 6 Cancer Imaging Center, Seoul National University Hospital, Seoul 03080, Korea 7 Institute on Aging, Seoul National University, Seoul 08826, Korea 8 Bio-MAX Institute, Seoul National University, Seoul 08826, Korea * Correspondence: [email protected] (M.G.S.); [email protected] (K.W.K.); Tel.: +82-2-2072-2803 (K.W.K.) Received: 18 September 2020; Accepted: 22 October 2020; Published: 26 October 2020 Abstract: Cisplatin (cis-diamminedichloroplatinum (II), CDDP) is a chemotherapeutic drug widely used against many solid tumors. -
VECTASTAIN® ABC Kit Reagents Should Be Stored at 2-8 °C
COMPONENTS STAINING PROCEDURE Reagents supplied: 1. For paraffin sections, deparaffinize and hydrate through xylenes or other clearing agents and graded alcohol series. • Blocking Serum (Normal Serum) in yellow-labeled small bottle – 3 ml For frozen sections or cell preparations fix with acetone or an appropriate • Biotinylated, Affinity-purified Anti-Immunoglobulin in blue-labeled small fixative for the antigen under study, if necessary. bottle – 1 ml Wash for 5 minutes in tap water. • Reagent A (Avidin DH) in orange-labeled small bottle – 2 ml 2. If antigen unmasking is required, perform this procedure using a Vector® • Reagent B (Biotinylated Horseradish Peroxidase H) in brown-labeled small Antigen Unmasking Solution, Citrate-based, pH 6.0 (H-3300) or Tris-based, pH bottle – 2 ml 9.0 (H-3301). ® The VECTASTAIN ABC Kit contains sufficient reagents to stain approximately 1000- 3. If quenching of endogenous peroxidase activity is required, incubate the 2000 tissue sections. slides in BLOXALL™ Blocking Solution (SP-6000) for 10 minutes. If endogenous peroxidase activity does not present a problem, this step may be omitted. For ® NOTE: The VECTASTAIN ABC Kit (Standard), Cat. No. PK-4000, contains only alternative quenching procedures please see Note 3. Reagent A and Reagent B. ® 4. Wash in buffer for 5 minutes. VECTASTAIN ABC KIT Storage: Stock VECTASTAIN® ABC Kit reagents should be stored at 2-8 °C. 5. Incubate for 20 minutes with diluted normal blocking serum. (In cases where non-specific staining is not a problem, steps 5 and 6 can be omitted).* Reagents not supplied: INSTRUCTIONS FOR 6. Blot excess serum from sections. -
Albumin (Human) 25% Solution, Usp
PRODUCT MONOGRAPH ALBUMIN (HUMAN) 25% SOLUTION, USP Albumin (Human) 25%, USP Intravenous Solution, 25% Manufacturer’s Standard Plasma Substitute/Blood Derivative Manufactured by: Imported and Distributed by: Date of Approval: Grifols Therapeutics Inc. Grifols Canada Ltd. December 19, 2011 8368 U.S. 70 Bus. Hwy West 5060 Spectrum Way, Clayton, North Carolina Suite 405 27520 Mississauga, Ontario U.S.A. L4W 5N5 Prepared for: Canadian Blood Services Ottawa, Ontario K1G 4J5 Prepared for: Héma-Québec Saint-Laurent, Québec H4R 2W7 Submission Control No: 152126 Page 1 of 19 Table of Contents PART I: HEALTH PROFESSIONAL INFORMATION..........................................................3 SUMMARY PRODUCT INFORMATION ........................................................................3 DESCRIPTION....................................................................................................................3 INDICATIONS AND CLINICAL USE..............................................................................3 CONTRAINDICATIONS ...................................................................................................6 WARNINGS AND PRECAUTIONS..................................................................................6 ADVERSE REACTIONS....................................................................................................7 DRUG INTERACTIONS ....................................................................................................8 DOSAGE AND ADMINISTRATION................................................................................8 -
Monoclonal Anti-Bovine Serum Albumin Antibody
Product No. B-2901 Lot 027H4822 Monoclonal Anti-Bovine Serum Albumin (BSA) Mouse Ascites Fluid Clone BSA-33 Monoclonal Anti-Bovine Serum Albumin (BSA) Description (mouse IgG2a isotype) is produced by the fusion of mouse myeloma cells and splenocytes from an immu- Bovine serum albumin is the major protein produced by nized mouse. Bovine serum albumin was used as the the liver and represents more than half of the total immunogen. The isotype is determined using Sigma protein found in serum. BSA is found in many biologi- ImmunoTypeTM Kit (Sigma Stock No. ISO-1) and by a cal substances such as serum supplemented cell culture double diffusion immunoassay using Mouse Mono- media and its products, in foods and forensic prepara- clonal Antibody Isotyping Reagents (Sigma Stock No. tions. A monoclonal antibody of species specificity ISO-2). The product is provided as a liquid with 0.1% may prove useful in the identification of bovine serum sodium azide (see MSDS)* as a preservative. albumin. Specificity Uses Monoclonal Anti-BSA recognizes the 67 kD band of Monoclonal Anti-Bovine Serum Albumin may be used SDS-denatured and reduced BSA using an immunoblot- for determination and quantification of BSA by ELISA, ting technique. The antibody is specific for bovine competitive ELISA and immunodot blot. The antibody serum albumin and is highly cross reactive with goat may be used for the immunoaffinity purification and and sheep serum albumins. The product is somewhat removal of BSA from various biological fluids such as less cross reactive with dog, turkey and horse serum cell culture media and in vitro-produced monoclonal albumins. -
Sex Hormone-Binding Globulin (SHBG) As an Early Biomarker and Therapeutic Target in Polycystic Ovary Syndrome
International Journal of Molecular Sciences Review Sex Hormone-Binding Globulin (SHBG) as an Early Biomarker and Therapeutic Target in Polycystic Ovary Syndrome Xianqin Qu 1,* and Richard Donnelly 2 1 School of Life Sciences, University of Technology Sydney, Ultimo, NSW 2007, Australia 2 School of Medicine, University of Nottingham, Derby DE22 3DT, UK; [email protected] * Correspondence: [email protected]; Tel.: +61-2-95147852 Received: 1 October 2020; Accepted: 28 October 2020; Published: 1 November 2020 Abstract: Human sex hormone-binding globulin (SHBG) is a glycoprotein produced by the liver that binds sex steroids with high affinity and specificity. Clinical observations and reports in the literature have suggested a negative correlation between circulating SHBG levels and markers of non-alcoholic fatty liver disease (NAFLD) and insulin resistance. Decreased SHBG levels increase the bioavailability of androgens, which in turn leads to progression of ovarian pathology, anovulation and the phenotypic characteristics of polycystic ovarian syndrome (PCOS). This review will use a case report to illustrate the inter-relationships between SHBG, NAFLD and PCOS. In particular, we will review the evidence that low hepatic SHBG production may be a key step in the pathogenesis of PCOS. Furthermore, there is emerging evidence that serum SHBG levels may be useful as a diagnostic biomarker and therapeutic target for managing women with PCOS. Keywords: adolescents; hepatic lipogenesis; human sex hormone-binding globulin; insulin resistance; non-alcoholic fatty liver disease; polycystic ovary syndrome 1. Introduction Polycystic ovary syndrome (PCOS) is a complex, common reproductive and endocrine disorder affecting up to 10% of reproductive-aged women [1]. -
Biochemical Characterization of Multiple Myeloma Patients Across ISS Stages – a Data
apjcc.waocp.com Noorjahan Mohammed, et al: Biochemical Characterization of Multiple Myeloma Patients across ISS Stages – A Data DOI:10.31557/APJCC.2019.4.3.77 RESEARCH ARTICLE Biochemical Characterization of Multiple Myeloma Patients across ISS Stages – A Data Base Workup from a Tertiary Care Hospital in India Noorjahan Mohammed1, KSS SaiBaba1, Yadagiri.B1, Sadasivudu Gundeti2, Sree Bhushan Raju3 1Department of Biochemistry, Hyderabad, Telangana, India 500082. 2Department of Medical Oncology, Hyderabad, Telangana, India 500082. 3Department of Nephrology, Nizam’s Institute of Medical Sciences, Hyderabad, Telangana, India 500082. Abstract Background: Multiple myeloma (MM) is slowly becoming a huge medical burden, challenging the health-care systems of Asian countries. Because of the unavailability of widespread access to various modalities of investigations, and paucity of well compiled data on common presenting features and various laboratory parameters in various stages of MM in India, the diagnosis is usually delayed till complications begin to occur. This study is an attempt to fill this gap and to establish database for future reference. Methods: The study was conducted in a tertiary health care centre over a span of 3 years and 94 patients diagnosed as MM with complete workup including beta2 microglobulin (β2M), bone marrow plasma cell percentage, serum protein electrophoresis, serum and urine Immunofixation and serum Free Light Chains (FLC) were included. The various laboratory parameters were statistically analyzed across ISS stages I, II and III. Results: We found a male to female ratio of 1.47:1. The mean age of patients was 55.5±11.78 yrs. Backache was the most frequent presentation (30%) of the patients followed by generalized weakness (22%). -
The Influence of Oxidative Stress on Serum Albumin Structure As A
pharmaceuticals Article The Influence of Oxidative Stress on Serum Albumin Structure as a Carrier of Selected Diazaphenothiazine with Potential Anticancer Activity Małgorzata Maci ˛azek-Jurczyk˙ 1,* , Beata Morak-Młodawska 2 , Małgorzata Jele ´n 2 , Wiktoria Kope´c 1, Agnieszka Szkudlarek 1 , Aleksandra Owczarzy 1, Karolina Kulig 1, Wojciech Rogóz˙ 1 and Jadwiga Pozycka˙ 1 1 Department of Physical Pharmacy, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, 40-055 Katowice, Poland; [email protected] (W.K.); [email protected] (A.S.); [email protected] (A.O.); [email protected] (K.K.); [email protected] (W.R.); [email protected] (J.P.) 2 Department of Organic Chemistry, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, 40-055 Katowice, Poland; [email protected] (B.M.-M.); [email protected] (M.J.) * Correspondence: [email protected]; Tel.: +48-32-364-15-80 Abstract: Albumin is one of the most important proteins in human blood. Among its multiple functions, drug binding is crucial in terms of drug distribution in human body. This protein undergoes many modifications that are certain to influence protein activity and affect its structure. One such reaction is albumin oxidation. Chloramine T is a strong oxidant. Solutions of human serum albumin, both non-modified and modified by chloramine T, were examined with the use of fluorescence, ˙ Citation: Maci ˛azek-Jurczyk, M.; absorption and circular dichroism (CD) spectroscopy. 10H-3,6-diazaphenothiazine (DAPT) has Morak-Młodawska, B.; Jele´n,M.; anticancer activity and it has been studied for the first time in terms of binding with human serum Kope´c,W.; Szkudlarek, A.; Owczarzy, albumin—its potential as a transporting protein.